Skip to search.
 TSX Down 0.52% TSX Ventures Down 0.66%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
55.51 Down 0.62(1.10%) 1:52PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:56.13
Open:55.40
Bid:55.65 x 100
Ask:55.70 x 100
1y Target Est:68.78
Beta:2.16
Earnings Date:Aug 3 - Aug 7 (Est.)
Day's Range:55.01 - 57.35
52wk Range:27.37 - 77.80
Volume:1,664,372
Avg Vol (3m):2,435,700
Market Cap:6.65B
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ISISDown 1.10%6.65B
ENZUp 0.69%134.95M
GILDUp 0.24%169.48B
SRPTDown 1.39%1.23B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.30
Quarterly EPS Est (Jun-15) :0.31
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-8.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback